Hyperbaric Oxygen Therapy for Diabetic Lower‐Limb Wounds in the Caribbean: A Retrospective Cohort Study
International Wound Journal · 2026-09 · 23 (9)
DOI: 10.1111/iwj.71040 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Wound Journal, online erschienen am 14.09.2026. Verfasst von Vanéva Chingan Martino und 4 weiteren Autor:innen. Beteiligte Einrichtung: Diabetic Foot Unit, University Hospital of Guadeloupe, Pointe-à-Pitre, France. Hauptthemen laut MEDLINE: Hyperbaric Oxygenation, Diabetic Foot, Wound Healing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Hyperbaric oxygen therapy (HBOT) is an established adjunctive treatment for selected diabetic foot ulcers, although evidence regarding its effectiveness remains heterogeneous. We conducted a retrospective, single‐center, observational study of adult diabetic patients receiving HBOT (2.5 ATA, 100% oxygen) for a lower‐limb wound at the only hyperbaric center in Guadeloupe, a French Caribbean territory, between January 2020 and June 2023. Among 257 patients treated with HBOT, 71 diabetic patients met inclusion criteria (mean age 63.1 ± 12.7 years; 69% male). Peripheral arterial disease and osteitis were highly prevalent, while the proportion of current smokers (7.9%) was notably lower than in previously published HBOT cohorts, a distinctive feature of this population. HBOT was considered a last resort, after failure of prolonged conventional therapy, in 63% of patients, likely contributing to the modest six‐month healing rate of 34% (18/53 evaluable patients) and 19% rate of major amputation occurring during or after HBOT. Patients referred through the multidisciplinary Diabetic Foot Care Unit had fewer major amputations despite older age and greater vascular burden, though this comparison may reflect referral‐related selection bias. No candidate factor, including glycemic control, referral pathway, or delay to HBOT, reached statistical significance in univariable analysis. This descriptive, single‐arm finding cannot establish HBOT efficacy but is consistent with a role for HBOT within coordinated multidisciplinary diabetic foot care, highlighting the importance of earlier referral and optimised patient selection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Diabetic Foot Unit, University Hospital of Guadeloupe, Pointe-à-Pitre, France.
- Caribbean Clinical Investigation Center, Inserm CIC 2504, University Hospital of Guadeloupe, Pointe-à-Pitre, Guadeloupe, France.
- Medical Informatics Department, University Hospital of Guadeloupe, Pointe-à-Pitre, France.
- LGL-TPE, Univ Lyon, Univ Lyon 1, ENSL, CNRS, UMR 5276, Villeurbanne, France.
- University of French West Indies, INSERM-CIC-1424, Centre Hospitalier Universitaire, Pointe-à-Pitre, France.
- University Hospital of Guadeloupe, Service Plateforme de Diagnostic et Thérapeutique Pluridisciplinaire, Pointe-à-Pitre, France.
ORCID-Profile: Vanéva Chingan Martino, Dominique Gibert
Zitieren
APA
Chingan Martino, V., Pusel, M., Bouamama, D., Gibert, D., & Cheret, A. (2026). Hyperbaric Oxygen Therapy for Diabetic Lower‐Limb Wounds in the Caribbean: A Retrospective Cohort Study. International Wound Journal, 23(9). https://doi.org/10.1111/iwj.71040
Vancouver
Chingan Martino V, Pusel M, Bouamama D, Gibert D, Cheret A. Hyperbaric Oxygen Therapy for Diabetic Lower‐Limb Wounds in the Caribbean: A Retrospective Cohort Study. International Wound Journal. 2026;23(9). doi:10.1111/iwj.71040
BibTeX
@article{ChinganMartino2026,
author = {Chingan Martino, Vanéva and Pusel, Marc and Bouamama, Djamel and Gibert, Dominique and Cheret, Antoine},
title = {Hyperbaric Oxygen Therapy for Diabetic Lower‐Limb Wounds in the Caribbean: A Retrospective Cohort Study},
journal = {International Wound Journal},
year = {2026},
volume = {23},
number = {9},
doi = {10.1111/iwj.71040}
}
EUVIMED